Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Kazuhiro Uesugi"'
Autor:
Keigo Honoki, Kinya Nishida, Yong Ho Che, Kazuhiro Uesugi, Akane Maeda, Jun Tsujino, Kazunori Ohno
Publikováno v:
Trauma Case Reports, Vol 30, Iss , Pp 100369- (2020)
Distal radius fracture is a common injury, especially in elderly people, and internal fixation with volar locking plate (VLP) is becoming an increasingly popular technique for the management of displaced and/or unstable distal radius fractures. One o
Externí odkaz:
https://doaj.org/article/051282d7fa19424782668d98f498f48a
Publikováno v:
Open Journal of Orthopedics. 12:131-141
Autor:
Kazuhiro Uesugi
Publikováno v:
Japanese Journal of Human Geography. 74:217-219
Autor:
Teruki Miyake, Yoichi Hiasa, Masanori Abe, Kozue Kanemitsu, Mari Nishiyama, Kazuhiro Tange, Atsushi Yukimoto, Mitsuhito Koizumi, Teru Kumagi, Yoshinori Ohno, Naozumi Shibata, Yoshinori Tanaka, Tomoyuki Yokota, Yoshiki Imamura, Kazuhiro Uesugi, Hideki Miyata, Taira Kuroda, Hiroshi Ishii, Takashi Terao, Yoshiyasu Kisaka, Nobuaki Azemoto
Publikováno v:
Internal Medicine
Objective The long-term effect of the ABO blood type on the clinical course of patients with pancreatic cancer (PC) is inconclusive. This study aimed to determine whether or not the ABO blood type influences the long-term outcomes of PC in Japanese p
Autor:
Kazuhiro Uesugi
Publikováno v:
Japanese Journal of Human Geography. 73:261-263
Autor:
Atsushi Yukimoto, Mari Nishiyama, Takashi Terao, Kozue Kanemitsu, Yoichi Hiasa, Naozumi Shibata, Yoshiyasu Kisaka, Kazuhiro Tange, Yoshinori Tanaka, Hideki Miyata, Yoshiki Imamura, Mitsuhito Koizumi, Yoshinori Ohno, Hiroshi Ishii, Nobuaki Azemoto, Taira Kuroda, Teru Kumagi, Teruki Miyake, Tomoyuki Yokota, Kazuhiro Uesugi
Publikováno v:
Mayo Clinic Proceedings. 94:2004-2010
Objective To evaluate whether patients with hepatitis B virus (HBV)– and hepatitis C virus (HCV)–related chronic liver disease were diagnosed as having pancreatic cancer (PC) at an early stage during abdominal imaging surveillance for hepatocellu
Autor:
Nobumasa Mizuno, Katsuhiro Omae, Kentaro Sudo, Akiko Todaka, Marina Kobayashi, Kazuhiro Uesugi, Seigo Yukisawa, Noritoshi Kobayashi, Hirofumi Fujii, Hideki Ueno, Satoshi Kobayashi, Keiko Kamei, Akira Fukutomi, Hiromichi Shirasu, Naohiro Okano, Masato Ozaka, Hideyuki Hayashi, Yosuke Horita
Publikováno v:
Cancer Science
Studies have indicated an association between UDP-glucuronosyltransferase-1A1 (UGT1A1) genetic polymorphisms and irinotecan-induced toxicity. We undertook this study to investigate the association between UGT1A1 genetic polymorphisms and toxicity in
Autor:
Akiko Todaka, Naohiro Okano, Noritoshi Kobayashi, Yosuke Horita, Hideki Ueno, Nobumasa Mizuno, Kazuhiro Uesugi, Atsushi Yamaguchi, Akira Fukutomi, Masato Ozaka, Keiko Kamei, Takashi Uchiyama, Shuhei Suzuki, Hideyuki Hayashi, Kentaro Sudo, Katsuhiro Omae, Shin Ishihara, Satoshi Kobayashi
Publikováno v:
Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]. 20(7)
Background Data on FOLFIRINOX as a second-line chemotherapy for advanced pancreatic cancer are limited. In the JASPAC06 study—a nationwide, multicenter, observational study—FOLFIRINOX for patients with unresectable or recurrent pancreatic cancer
Autor:
Yukio Yoshida, Kazuhiko Shioji, Kazuhiro Uesugi, Kumiko Umemoto, Takeshi Terashima, Chigusa Morizane, Masayo Motoya, Hideaki Takahashi, Tetsuo Akimoto, Makoto Ueno, Masafumi Ikeda, Ikuhiro Yamada, Satoshi Shimizu, Junji Furuse, Nobumasa Mizuno, Yasushi Kojima
Publikováno v:
Cancer Chemotherapy and Pharmacology
Background UGT1A1 *28 and *6 polymorphism is associated with reduced enzyme activity and severe toxicities of irinotecan, especially in patients with homozygous or heterozygous for UGT1A1*28 or *6 polymorphism for both UGT1A1*28 and *6 (double-varian
Autor:
Noritoshi Kobayashi, Masato Ozaka, Akiko Todaka, Shoji Nakamori, Kazuhiro Uesugi, Narikazu Boku, Hideki Ueno, Seigo Yukisawa, Naohiro Okano, Keiko Kamei, Hideyuki Hayashi, Yosuke Horita, Satoshi Kobayashi, Yutaka Yachi, Keita Mori, Akira Fukutomi, Toshiyuki Henmi, Marina Kobayashi, Kentaro Sudo, Nobumasa Mizuno
Publikováno v:
Pancreas. 47:631-636
OBJECTIVES FOLFIRINOX (oxaliplatin, irinotecan, 5-fluorouracil, and leucovorin) is the standard therapy worldwide for unresectable pancreatic cancer; however, clinical data for Japanese patients are limited. Therefore, the observational study of FOLF